Person · CIK 1649245

Phillip G. Febbo

Chief Scientific & Med Officer at Veracyte

Earlier: Illumina, Varian Medical Systems and Genomic Health

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$4.2M

Noticed on Form 144$1.8M

Bought on Form 4$0

Companies4

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Veracyte VCYT	Common Stock	Directly	133,048	Sep 4, 2026 · Filing · EDGAR
Veracyte VCYT	Stock Option (right to buy) exercise $21.96, expires Oct 2, 2033, into Common Stock	Directly	85,858	Oct 2, 2023 · Filing · EDGAR
Illumina	Common Stock	Directly	14,786	Mar 1, 2023 · Filing · EDGAR
Varian Medical Systems	Common Stock	By Roth IRA	9	Feb 16, 2021 · Filing · EDGAR
Genomic Health	Common Stock	Directly	21,387	Feb 20, 2018 · Filing · EDGAR
Genomic Health	Employee Stock Option (right to buy) Holding exercise $33.21, expires Jan 31, 2028, into Common Stock	Directly	26,060	Jan 31, 2018 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q3 2026	$564K	$586K
Q1 2026	$485K	$491K
Q4 2025	$301K	$301K
Q1 2025	$268K	$270K
Q4 2024	$173K	$172K
Q2 2022	$716K	Not machine-readable
Q4 2021	$407K	Not machine-readable
Q2 2021	$448K	Not machine-readable
Q4 2020	$48K	Not machine-readable
Q2 2020	$52K	Not machine-readable
Q4 2019	$47K	Not machine-readable
Q1 2018	$162K	Not machine-readable
Q4 2017	$197K	Not machine-readable
Q3 2017	$107K	Not machine-readable
Q1 2017	$75K	Not machine-readable
Q2 2016	$172K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Aug 21, 2025 · 2 notices
Sep 4, 2026	13,110 · ~$586K	Sep 4, 2026	Sold as noticed Sold 13,110 in 2 sales, Sep 4 to Sep 4 · $564K Form 4	Filing · EDGAR
Mar 2, 2026	13,425 · ~$491K	Mar 2, 2026	Sold as noticed Sold 13,425 at $36.16 on Mar 2 · $485K Form 4	Filing · EDGAR
Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Sep 4, 2024 · 4 notices
Oct 6, 2025	8,349 · ~$301K	Oct 6, 2025	Sold as noticed Sold 8,349 at $36.02 on Oct 6 · $301K Form 4	Filing · EDGAR
Mar 4, 2025	8,037 · ~$270K	Mar 4, 2025	Sold as noticed Sold 8,037 in 2 sales, Mar 4 to Mar 4 · $268K Form 4	Filing · EDGAR
Dec 5, 2024	1,311 · ~$58K	Dec 4, 2024	Not sold within 90 days	Filing · EDGAR
Dec 4, 2024	2,623 · ~$115K	Dec 4, 2024	Not sold within 90 days	Filing · EDGAR
Sales without a matching Form 144 · 19 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Veracyte (VCYT): Sold 3,934 at $44.09 on Dec 4, 2024 · $173K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,988 at $360.01 on Apr 6, 2022 · $716K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 1,000 at $406.83 on Nov 8, 2021 · $407K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 290 at $449.02 on Jun 11, 2021 · $130K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 400 at $447.65 on Jun 11, 2021 · $179K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 310 at $446.17 on Jun 11, 2021 · $138K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 155 at $310.10 on Nov 6, 2020 · $48K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 173 at $300.00 on Apr 16, 2020 · $52K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Illumina: Sold 155 at $300.00 on Nov 14, 2019 · $47K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 300 at $33.35 on Feb 20, 2018 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 4,642 at $32.81 on Feb 20, 2018 · $152K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 334 at $36.82 on Dec 19, 2017 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 5,000 at $37.00 on Dec 19, 2017 · $185K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 330 at $33.57 on Jul 19, 2017 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 2,844 at $33.57 on Jul 19, 2017 · $95K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 1,226 at $30.63 on Feb 16, 2017 · $38K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 1,269 at $29.56 on Feb 16, 2017 · $38K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 100 at $28.13 on May 10, 2016 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Genomic Health: Sold 6,224 at $27.19 on May 10, 2016 · $169K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Veracyte VCYT Chief Scientific & Med Officer · filings 2023 to 2026 · sold $1.8M · $1.8M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 4, 2026	Sale under a 10b5-1 plan	−10,405	$42.89	$446K	135,753 direct	Filing · EDGAR
Sep 4, 2026	Sale under a 10b5-1 plan	−2,705	$43.66	$118K	133,048 direct	Filing · EDGAR
Sep 2, 2026	Shares withheld for tax or exercise price	−3,639	$44.88	$163K	146,158 direct	Filing · EDGAR
Jun 2, 2026	Shares withheld for tax or exercise price	−3,730	$47.80	$178K	149,797 direct	Filing · EDGAR
Mar 6, 2026	Grant or award from the company	+29,603			146,949 direct	Filing · EDGAR
Mar 6, 2026	Grant or award from the company	+6,578			153,527 direct	Filing · EDGAR
Mar 2, 2026	Shares withheld for tax or exercise price	−6,035	$36.01	$217K	130,771 direct	Filing · EDGAR
Mar 2, 2026	Sale under a 10b5-1 plan	−13,425	$36.16	$485K	117,346 direct	Filing · EDGAR
Feb 26, 2026	Grant or award from the company	+71,806			161,292 direct	Filing · EDGAR
Feb 26, 2026	Shares withheld for tax or exercise price	−24,486	$38.75	$949K	136,806 direct	Filing · EDGAR
Dec 2, 2025	Shares withheld for tax or exercise price	−2,955	$46.16	$136K	89,486 direct	Filing · EDGAR
Oct 6, 2025	Sale under a 10b5-1 plan	−8,349	$36.02	$301K	92,441 direct	Filing · EDGAR
Sep 2, 2025	Shares withheld for tax or exercise price	−2,955	$30.11	$89K	100,790 direct	Filing · EDGAR
Jun 2, 2025	Shares withheld for tax or exercise price	−2,955	$26.74	$79K	103,745 direct	Filing · EDGAR
Mar 6, 2025	Grant or award from the company	+24,160			106,700 direct	Filing · EDGAR
Mar 4, 2025	Sale under a 10b5-1 plan	−4,467	$32.86	$147K	86,110 direct	Filing · EDGAR
Mar 4, 2025	Sale under a 10b5-1 plan	−3,570	$33.95	$121K	82,540 direct	Filing · EDGAR
Mar 2, 2025	Shares withheld for tax or exercise price	−6,754	$34.76	$235K	90,577 direct	Filing · EDGAR
Feb 27, 2025	Grant or award from the company	+30,589			113,003 direct	Filing · EDGAR
Feb 27, 2025	Shares withheld for tax or exercise price	−15,672	$33.84	$530K	97,331 direct	Filing · EDGAR
Dec 4, 2024	Sale under a 10b5-1 plan	−3,934	$44.09	$173K	82,414 direct	Filing · EDGAR
Dec 2, 2024	Shares withheld for tax or exercise price	−6,738	$44.12	$297K	86,348 direct	Filing · EDGAR
Mar 6, 2024	Grant or award from the company	+39,904			93,086 direct	Filing · EDGAR
Oct 2, 2023	Grant or award from the company	+53,182			53,182 direct	Filing · EDGAR
Oct 2, 2023	Grant or award from the company Stock Option (right to buy)	+85,858			85,858 direct	Filing · EDGAR

Illumina SVP Chief Medical Officer · filings 2019 to 2023 · sold $1.7M

Date	Transaction	Shares	Price	Value	Held after	Source
Mar 1, 2023	Grant or award from the company	+7,556			14,786 direct	Filing · EDGAR
Mar 1, 2023	Grant or award from the company Performance Shares	+3,023			3,023 direct	Filing · EDGAR
Mar 1, 2023	Grant or award from the company Performance Shares	+4,534			4,534 direct	Filing · EDGAR
Feb 21, 2023	Option or RSU exercised or converted	+3,522			8,475 direct	Filing · EDGAR
Feb 21, 2023	Shares withheld for tax or exercise price	−1,245	$202.84	$253K	7,230 direct	Filing · EDGAR
Feb 21, 2023	Option or RSU exercised or converted Performance Shares	−3,522			0 direct	Filing · EDGAR
Nov 5, 2022	Shares withheld for tax or exercise price	−821	$217.19	$178K	4,953 direct	Filing · EDGAR
Apr 6, 2022	Sale under a 10b5-1 plan	−1,988	$360.01	$716K	5,774 direct	Filing · EDGAR
Apr 5, 2022	Shares withheld for tax or exercise price	−131	$363.84	$48K	7,762 direct	Filing · EDGAR
Mar 1, 2022	Grant or award from the company	+3,029			7,893 direct	Filing · EDGAR
Mar 1, 2022	Grant or award from the company Performance Shares	+9,085			9,085 direct	Filing · EDGAR
Feb 22, 2022	Option or RSU exercised or converted	+2,851			5,866 direct	Filing · EDGAR
Feb 22, 2022	Shares withheld for tax or exercise price	−1,002	$319.86	$320K	4,864 direct	Filing · EDGAR
Feb 22, 2022	Option or RSU exercised or converted Performance Shares	−2,851			0 direct	Filing · EDGAR
Nov 8, 2021	Sale under a 10b5-1 plan	−1,000	$406.83	$407K	3,015 direct	Filing · EDGAR
Nov 5, 2021	Shares withheld for tax or exercise price	−446	$408.14	$182K	4,015 direct	Filing · EDGAR
Jun 11, 2021	Sale under a 10b5-1 plan	−310	$446.17	$138K	5,151 direct	Filing · EDGAR
Jun 11, 2021	Sale under a 10b5-1 plan	−400	$447.65	$179K	4,751 direct	Filing · EDGAR
Jun 11, 2021	Sale under a 10b5-1 plan	−290	$449.02	$130K	4,461 direct	Filing · EDGAR
Apr 5, 2021	Shares withheld for tax or exercise price	−131	$384.54	$50K	5,461 direct	Filing · EDGAR
Feb 17, 2021	Grant or award from the company	+350			3,873 direct	Filing · EDGAR
Feb 17, 2021	Option or RSU exercised or converted	+3,173			7,046 direct	Filing · EDGAR
Feb 17, 2021	Shares withheld for tax or exercise price	−1,454	$494.24	$719K	5,592 direct	Filing · EDGAR
Feb 17, 2021	Option or RSU exercised or converted Performance Shares	−3,173			0 direct	Filing · EDGAR
Feb 9, 2021	Grant or award from the company	+1,380			3,523 direct	Filing · EDGAR
Feb 9, 2021	Grant or award from the company Performance Shares	+4,140			4,140 direct	Filing · EDGAR
Nov 6, 2020	Sale under a 10b5-1 plan	−155	$310.10	$48K	2,143 direct	Filing · EDGAR
Nov 5, 2020	Shares withheld for tax or exercise price	−192	$311.72	$60K	2,298 direct	Filing · EDGAR
Apr 16, 2020	Sale under a 10b5-1 plan	−173	$300.00	$52K	2,490 direct	Filing · EDGAR
Apr 5, 2020	Shares withheld for tax or exercise price	−92	$278.01	$26K	2,663 direct	Filing · EDGAR
Feb 5, 2020	Grant or award from the company	+1,249			2,755 direct	Filing · EDGAR
Feb 5, 2020	Grant or award from the company Performance Shares	+3,746			3,746 direct	Filing · EDGAR
Nov 14, 2019	Sale under a 10b5-1 plan	−155	$300.00	$47K	1,506 direct	Filing · EDGAR
Nov 5, 2019	Shares withheld for tax or exercise price	−83	$300.87	$25K	1,661 direct	Filing · EDGAR

Varian Medical Systems Director · filings 2019 to 2021

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 15, 2021	Returned to the company	−1,699	$177.50	$302K	0 direct	Filing · EDGAR
Apr 15, 2021	Returned to the company Restricted Stock Units	−1,022			0 direct	Filing · EDGAR
Feb 16, 2021	Option or RSU exercised or converted	+1,225			1,699 direct	Filing · EDGAR
Feb 16, 2021	Option or RSU exercised or converted Restricted Stock Units	−1,225			0 direct	Filing · EDGAR
Feb 11, 2021	Grant or award from the company Restricted Stock Units	+1,022			1,022 direct	Filing · EDGAR
Feb 14, 2020	Option or RSU exercised or converted	+474			474 direct	Filing · EDGAR
Feb 14, 2020	Grant or award from the company Restricted Stock Units	+474			474 direct	Filing · EDGAR
Feb 14, 2020	Option or RSU exercised or converted Restricted Stock Units	−474			0 direct	Filing · EDGAR
Feb 14, 2020	Grant or award from the company Restricted Stock Units	+1,225			1,225 direct	Filing · EDGAR

Genomic Health Chief Medical Officer · filings 2015 to 2018 · sold $713K

Date	Transaction	Shares	Price	Value	Held after	Source
Feb 20, 2018	Sale under a 10b5-1 plan	−4,642	$32.81	$152K	21,687 direct	Filing · EDGAR
Feb 20, 2018	Sale under a 10b5-1 plan	−300	$33.35	$10K	21,387 direct	Filing · EDGAR
Feb 15, 2018	Shares withheld for tax or exercise price	−2,801	$32.66	$91K	26,329 direct	Filing · EDGAR
Jan 31, 2018	Grant or award from the company	+11,330			29,130 direct	Filing · EDGAR
Jan 31, 2018	Grant or award from the company Employee Stock Option (right to buy) Holding	+26,060			26,060 direct	Filing · EDGAR
Dec 19, 2017	Option or RSU exercised or converted	+5,000	$27.00	$135K	23,134 direct	Filing · EDGAR
Dec 19, 2017	Sale under a 10b5-1 plan	−5,000	$37.00	$185K	18,134 direct	Filing · EDGAR
Dec 19, 2017	Sale under a 10b5-1 plan	−334	$36.82	$12K	17,800 direct	Filing · EDGAR
Dec 19, 2017	Option or RSU exercised or converted Employee Stock Option (right to buy) Holding	−5,000			9,710 direct	Filing · EDGAR
Jul 19, 2017	Sale under a 10b5-1 plan	−2,844	$33.57	$95K	18,130 direct	Filing · EDGAR
Jul 19, 2017	Sale under a 10b5-1 plan	−330	$33.57	$11K	17,800 direct	Filing · EDGAR
Feb 16, 2017	Sale under a 10b5-1 plan	−1,269	$29.56	$38K	21,870 direct	Filing · EDGAR
Feb 16, 2017	Sale under a 10b5-1 plan	−1,226	$30.63	$38K	20,644 direct	Filing · EDGAR
Feb 15, 2017	Shares withheld for tax or exercise price	−1,910	$31.12	$59K	23,139 direct	Filing · EDGAR
Jan 31, 2017	Grant or award from the company	+11,440			25,049 direct	Filing · EDGAR
Jan 31, 2017	Grant or award from the company Employee Stock Option (right to buy) Holding	+26,320			26,320 direct	Filing · EDGAR
Aug 15, 2016	Shares withheld for tax or exercise price	−1,066	$27.00	$29K	13,241 direct	Filing · EDGAR
May 10, 2016	Sale under a 10b5-1 plan	−6,224	$27.19	$169K	15,113 direct	Filing · EDGAR
May 10, 2016	Sale under a 10b5-1 plan	−100	$28.13	$3K	15,013 direct	Filing · EDGAR
Feb 16, 2016	Grant or award from the company	+7,290			21,337 direct	Filing · EDGAR
Feb 16, 2016	Grant or award from the company Employee Stock Option (right to buy) Holding	+14,710			14,710 direct	Filing · EDGAR
Feb 15, 2016	Shares withheld for tax or exercise price	−1,255	$26.53	$33K	14,047 direct	Filing · EDGAR
Aug 15, 2015	Shares withheld for tax or exercise price	−1,065	$24.85	$26K	14,307 direct	Filing · EDGAR

All 57 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 4, 2026	Form 144	Veracyte VCYT	Filing · EDGAR
Sep 4, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 4, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 10, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 4, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 2, 2026	Form 144	Veracyte VCYT	Filing · EDGAR
Mar 2, 2026	Form 4	Veracyte VCYT	Filing · EDGAR
Dec 4, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Oct 7, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Oct 6, 2025	Form 144	Veracyte VCYT	Filing · EDGAR
Sep 4, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Jun 4, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 10, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 6, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 4, 2025	Form 144	Veracyte VCYT	Filing · EDGAR
Mar 3, 2025	Form 4	Veracyte VCYT	Filing · EDGAR
Dec 6, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Dec 5, 2024	Form 144	Veracyte VCYT	Filing · EDGAR
Dec 4, 2024	Form 144	Veracyte VCYT	Filing · EDGAR
Dec 4, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Mar 8, 2024	Form 4	Veracyte VCYT	Filing · EDGAR
Oct 4, 2023	Form 4	Veracyte VCYT	Filing · EDGAR
Oct 4, 2023	Form 3	Veracyte VCYT	Filing · EDGAR
Mar 3, 2023	Form 4	Illumina	Filing · EDGAR
Feb 23, 2023	Form 4	Illumina	Filing · EDGAR
Nov 8, 2022	Form 4	Illumina	Filing · EDGAR
Apr 7, 2022	Form 4	Illumina	Filing · EDGAR
Mar 3, 2022	Form 4	Illumina	Filing · EDGAR
Feb 24, 2022	Form 4	Illumina	Filing · EDGAR
Nov 9, 2021	Form 4	Illumina	Filing · EDGAR
Jun 14, 2021	Form 4	Illumina	Filing · EDGAR
Apr 16, 2021	Form 4	Varian Medical Systems	Filing · EDGAR
Apr 7, 2021	Form 4	Illumina	Filing · EDGAR
Feb 18, 2021	Form 4	Illumina	Filing · EDGAR
Feb 17, 2021	Form 4	Varian Medical Systems	Filing · EDGAR
Feb 16, 2021	Form 4	Varian Medical Systems	Filing · EDGAR
Feb 11, 2021	Form 4	Illumina	Filing · EDGAR
Nov 9, 2020	Form 4	Illumina	Filing · EDGAR
Apr 20, 2020	Form 4	Illumina	Filing · EDGAR
Apr 7, 2020	Form 4	Illumina	Filing · EDGAR
Feb 19, 2020	Form 4	Varian Medical Systems	Filing · EDGAR
Feb 7, 2020	Form 4	Illumina	Filing · EDGAR
Nov 18, 2019	Form 4	Illumina	Filing · EDGAR
Nov 7, 2019	Form 4	Illumina	Filing · EDGAR
Nov 7, 2019	Form 3	Illumina	Filing · EDGAR
Aug 28, 2019	Form 3	Varian Medical Systems	Filing · EDGAR
Feb 22, 2018	Form 4	Genomic Health	Filing · EDGAR
Feb 20, 2018	Form 4	Genomic Health	Filing · EDGAR
Feb 2, 2018	Form 4	Genomic Health	Filing · EDGAR
Dec 20, 2017	Form 4	Genomic Health	Filing · EDGAR
Jul 21, 2017	Form 4	Genomic Health	Filing · EDGAR
Feb 17, 2017	Form 4	Genomic Health	Filing · EDGAR
Feb 2, 2017	Form 4	Genomic Health	Filing · EDGAR
Dec 20, 2016	Form 4	Genomic Health	Filing · EDGAR
May 12, 2016	Form 4	Genomic Health	Filing · EDGAR
Feb 17, 2016	Form 4	Genomic Health	Filing · EDGAR
Jul 31, 2015	Form 3	Genomic Health	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 8, 2026, 6:44 AM ET. The filing on SEC.gov is the record.